HansBiomed Corporation
Research HansBiomed Corporation (042520.KQ) on Bullrun: market cap KRW 310.90B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker042520.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 310.90B
- Financial periodQ2 2026
- RevenueKRW 36.35B
- Net incomeKRW 1.93B
- Free cash flowKRW 2.78B
- Gross margin64.2%
Valuation Snapshot
latest market cap is KRW 310.90B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | KRW 310.90B | n/a | n/a | n/a |
About HansBiomed Corporation
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HansBiomed Corporation's market cap?
HansBiomed Corporation's market capitalization is KRW 310.90B.
What does HansBiomed Corporation do?
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.